Introduction
From Clinical Trials to RWE in PsO & AA
Objectives
1. Discuss how real-world experience shapes clinical practice and informs practical treatment decision-making.
2. Highlight how real-world experiences with ixekizumab in patients with plaque psoriasis (PsO) compare with data from randomized controlled trials, and address knowledge gaps
3. Highlight how Highlight how real-world experiences with
baricitinib in patients with Alopecia Areata (AA) compare with data from randomized controlled trials, and address knowledge gaps
This Course For :
Physician
( Dermatology )
Resident / Fellow
( Dermatology )
Clinical Pharmacy
Pharmacy
Speaker
Dr. Dana Alessa, MBBS
Assistant Professor and Consultant Dermatologist
King Saud bin Abdulaziz University for Health Sciences and Ministry of National Guard Health Affairs-Riyadh
Head of Scientific Committee-SSDDS and ADAM
Dr. Yousef Binamer
MD,EMBA,FRCPC,DABD,FAAD
Chairman, Department of Dermatology at King Faisal Specialist Hospital and Research Centre, Riyadh
Dr Afaf Sheikh
Consultant Dermatologist
Head division of Dermatology, Department of Medicine
King Abdulaziz Medical City, Riyadh
Assistant Professor, King Saud Bin Abdulaziz University for Health Sciences
Provided by :
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
20 Nov 2025 To 20 Nov 2025 -
09:00 PM To 10:30 PM 
Certificate Available 
Online
- 2
Add to Calendar
11/20/2025 09:00 PM
11/20/2025 10:30 PM
Asia/ Riyadh
Transition from Clinical Trials to RWE in Psoriasis & Alopecia Areata
Transition from Clinical Trials to RWE in Psoriasis & Alopecia Areata
https://medicalacademy.org/portal/event/view/2486
